Assessment Of Change In Quality Of Life (QOL), Carcinoid Syndrome (CS) Symptoms, And Health Care Resource Utilization (HRU) In Cs Patients Treated With Somatostatin Analogs (SSA) -- Results From Longitudinal Patient Surveys
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.320
https://www.valueinhealthjournal.com/article/S1098-3015(18)30620-X/fulltext
Section Title :
Section Order :
1086
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30620-X&doi=10.1016/j.jval.2018.04.320